<DOC>
	<DOCNO>NCT01874093</DOCNO>
	<brief_summary>The primary objective study assess safety effectiveness SPG stimulation ISS 24 hour window , patient acute ischemic stroke anterior circulation , receive IV-rtPA Standard Care .</brief_summary>
	<brief_title>THE IMPACT- 24Bt Post rtPA TRIAL ( IMPlant Augmenting Cerebral Blood Flow Trial 24 Hours From Stroke Onset , Post IV-rtPA )</brief_title>
	<detailed_description>This multi-center , multinational , randomize , double blind , sham control , adjunctive Standard Care , parallel arm study include ongoing DSMB review accumulate safety data . The study three phase : Phase I - Implantation Safety Assessment Number patient : 20 ( least 10 implantation ) - Implanters : certified implanters already perform implantation ISS previous study - Continue next phase serious procedure complication relate rtPA ( determined implanter ) . Otherwise , implement retirement continue DSMB approval . DSMB meeting : 10 implantation Phase II - Symptomatic Hemorrhage Assessment ( sICH ) : - Number patient : 50 ( additional 30 ) - Implanters : certify implanters - Continue next phase clinically meaningful difference treat control . A clinically meaningful difference difference 3 sICH case within first 5 day treatment , treat arm compare control arm . Otherwise , implement retirement continue DSMB approval . - DSMB meeting : 30 50 patient Phase III - Entire study population , DSMB meeting per quarter</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 . Age : ≥ 40 year ≤ 80 year male 85 female subject 2 . Clinical diagnosis acute ischemic stroke Carotid , Middle Anterior Cerebral Artery territories leave cerebral hemisphere 3 . Imaging finding demonstrate sign ischemia anterior circulation 4 . Administration IVrtPA within ≤ 4.5 hour stroke onset 5 . NIHSS ≥ 7 ≤ 18 clinical sign aphasia ( NIHSS best language score ≥ 1 ) 6 . Ability initiate treatment within ≤ 24 hour stroke onset 7 . Signed informed consent patient him/herself legally authorize representative applicable 1 . Neuroimaging evidence intracranial hemorrhage hemorrhagic transformation 2 . Massive stroke 3 . Acute stroke due lacunar infarct 4 . Acute stroke Posterior circulation 5 . Minor stroke 6 . Bilateral stroke 7 . Treated IArtPA neurothrombectomy device current stroke 8 . NIHSS level consciousness score ≥ 2 9 . Previous stroke last 6 month 10 . Preexisting disability ; Preexisting Modified Rankin Score &gt; 1 11 . Patients bleed propensity 12 . Known cerebral arteriovenous malformation , cerebral aneurysm 13 . Seizures onset 14 . Clinical suspicion septic embolus 15 . Uncontrolled hypertension ( systolic &gt; 185 mmHg and/or diastolic &gt; 110 mmHg ) 16 . Serious systemic infection . 17 . Women know pregnant positive indeterminate pregnancy test 18 . Patients implanted neural stimulator/ electronic device ( pacemaker ) 19 . History SPG ablation ipsilateral stroke side . 20 . Any condition oral cavity prevents implantation INS 21 . Life expectancy &lt; 1 year cause stroke . 22 . Participating therapeutic investigational trial within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>